Evidence map›Paper›PMID 41559192›Full record

ArticleNature biomedical engineering2026

Enhancing link prediction in biomedical knowledge graphs with BioPathNet.

Emy Yue Hu, Svitlana Oleshko, Samuele Firmani, Hui Cheng, Zhaocheng Zhu, Maria Ulmer, Matthias Arnold, Maria Colomé-Tatché, Jian Tang, Sophie Xhonneux and 1 more

Abstract read
In one paragraph

Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Emy Yue Hu *Computational Health Center, Helmholtz Center Munich, Oberschleißheim, Germany.
Svitlana Oleshko *Computational Health Center, Helmholtz Center Munich, Oberschleißheim, Germany.
Samuele Firmani *Computational Health Center, Helmholtz Center Munich, Oberschleißheim, Germany.ORCID http://orcid.org/0009-0007-2897-0315
Hui Cheng *School of Computation, Information and Technology, Technical University of Munich, Munich, Germany.
Zhaocheng ZhuMila - Québec AI Institute, Montréal, Quebec, Canada.
Maria UlmerComputational Health Center, Helmholtz Center Munich, Oberschleißheim, Germany.
Matthias ArnoldComputational Health Center, Helmholtz Center Munich, Oberschleißheim, Germany.ORCID http://orcid.org/0000-0002-4666-0923
Maria Colomé-TatchéComputational Health Center, Helmholtz Center Munich, Oberschleißheim, Germany.
Jian TangMila - Québec AI Institute, Montréal, Quebec, Canada.
Sophie XhonneuxMila - Québec AI Institute, Montréal, Quebec, Canada.
Annalisa MarsicoComputational Health Center, Helmholtz Center Munich, Oberschleißheim, Germany. annalisa.marsico@helmholtz-munich.de.ORCID http://orcid.org/0000-0003-0327-5555

Funding

Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-ADU01AG061359 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F, KASTENMULLER, GABI · 2018 to 2022
$10.0M
Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to TreatmentRF1AG059093 · NIA · DUKE UNIVERSITY · PI BRINTON, ROBERTA EILEEN, CHANG, RUI · 2018 to 2018
$5.9M
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's diseaseR01AG081322 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Matthias Arnold, Rima F Kaddurah-Daouk · 2023 to 2026
$2.6M
NIA NIH HHS R01 AG081322NIA NIH HHS RF1 AG059093NIA NIH HHS U01 AG061359
6 · The paper itself

Abstract

Understanding complex interactions in biomedical networks is crucial for advancements in biomedicine, but traditional link prediction (LP) methods are limited in capturing this complexity. We present BioPathNet, a graph neural network framework based on the neural Bellman-Ford network (NBFNet), addressing limitations of traditional representation-based learning methods through path-based reasoning for LP in biomedical knowledge graphs. Unlike node-embedding frameworks, BioPathNet learns representations between node pairs by considering all relations along paths, enhancing prediction accuracy and interpretability, and allowing visualization of influential paths and biological validation. BioPathNet leverages a background regulatory graph for enhanced message passing and uses stringent negative sampling to improve precision and scalability. BioPathNet outperforms or matches existing methods across diverse tasks including gene function annotation, drug-disease indication, synthetic lethality and lncRNA-target interaction prediction. Our study identifies promising additional drug indications for diseases such as acute lymphoblastic leukaemia and Alzheimer's disease, validated by medical experts and clinical trials. In addition, we prioritize putative synthetic lethal gene pairs and regulatory lncRNA-target interactions. BioPathNet's interpretability will enable researchers to trace prediction paths and gain molecular insights.

Indexed as

Computational BiologyAlgorithmsGraph Neural NetworksHumansNeural Networks, ComputerPrediction AlgorithmsRNA, Long NoncodingRNA, Long Noncoding

Identifiers

PMID41559192
PMCPMC13472943

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.